Aller au contenu principal
Accès ouvert déclaré 2025 article

Diagnostic accuracy of echomics in patients with transthyretin-related cardiacamyloidosis

0Citations signalées, ce qui n’est pas une note de qualité
7Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : it, by. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Background/Introduction The diagnosis of transthyretin-related cardiac amyloidosis (ATTR-CA), while often suggested by red flags observed in echocardiography, still requires a lengthy and multi-step process. Recent evidence indicates the feasibility of using radiomics on echocardiographic images (i.e., echomics) for the early characterization of myocardial texture anomalies in ATTR-CA. Aims This study aims to develop a radiomic-based model for the diagnosis of transthyretin-related cardiac amyloidosis (ATTR-CA) by characterizing myocardial tissue through echocardiography (echomics). Methods We retrospectively collected echocardiographic images in parasternal long-axis and apical 4-chamber views from ATTR-CA and control patients at four Italian centers. The largest possible region-of-interest (ROI) within the interventricular septum was delineated. Ninety-four radiomic features were extracted, including 9 shape-related features and 85 texture features, 21 of which depend on ROI dimensions and 73 purely texture-based (ROI-independent). Five logistic regression models were used to analyse data from three centres (229 ATTR-CA, 224 controls). The models estimated the diagnostic accuracy and area-under-the-curve (AUC) of different sets of radiomic features. The developed five models were finally tested on a cohort of patients from the fourth centre (32 ATTR-CA and 32 age- and sex-matched control patients) for external validation. Results The models that included shape and all texture features, whether separately or in combination, demonstrated very high cross-validated accuracies (93-95%) and AUC values (0.97-0.99). However, when using a fixed-size 0.5x0.5 cm ROI, these values decreased to 85% and 0.91, respectively. This confirms that some measurement depends on ROI size. The chosen model used 73 ROI independent features on the largest ROI and demonstrated significantly better accuracy and AUC (92% and 0.97, respectively, p<0.001). These results were confirmed in the external validation cohort (87% and 0.95, respectively). Removing the least informative features resulted in a slight model improvement 90% accuracy and 0.95 precision when 40 out of 73 features were used. Conclusions This study demonstrates the potential of echomics (i.e., radiomics applied to echocardiography data) to distinguish between ATTR-CA and control patients by identifying disease-specific textural features that are independent of ROI dimensions. Workflow Results

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Diagnostic accuracy of echomics in patients with transthyretin-related cardiacamyloidosis
Date Crossref
01/01/2025
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

S100 Proteins and AnnexinsAmyloidosis: Diagnosis, Treatment, OutcomesCardiac Imaging and Diagnostics

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.